Harvey PD - Search Results

1

A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.

Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S. Stahl SM, et al. Among authors: harvey pd. J Clin Psychopharmacol. 2010 Aug;30(4):425-30. doi: 10.1097/JCP.0b013e3181e69042. J Clin Psychopharmacol. 2010. PMID: 20571437 Clinical Trial.

2

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.

Harvey PD, Green MF, McGurk SR, Meltzer HY. Harvey PD, et al. Psychopharmacology (Berl). 2003 Sep;169(3-4):404-11. doi: 10.1007/s00213-002-1342-5. Epub 2003 Feb 18. Psychopharmacology (Berl). 2003. PMID: 12590356 Clinical Trial.

3

Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.

Harvey PD, Siu CO, Romano S. Harvey PD, et al. Psychopharmacology (Berl). 2004 Mar;172(3):324-32. doi: 10.1007/s00213-003-1652-2. Epub 2003 Nov 13. Psychopharmacology (Berl). 2004. PMID: 14615877 Clinical Trial.

4

Ziprasidone and cognition: the evolving story.

Harvey PD. Harvey PD. J Clin Psychiatry. 2003;64 Suppl 19:33-9. J Clin Psychiatry. 2003. PMID: 14728088

5

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.

Harvey PD, Meltzer H, Simpson GM, Potkin SG, Loebel A, Siu C, Romano SJ. Harvey PD, et al. Schizophr Res. 2004 Feb 1;66(2-3):101-13. doi: 10.1016/j.schres.2003.07.009. Schizophr Res. 2004. PMID: 15061242 Clinical Trial.

6

Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning.

Ginsberg DL, Schooler NR, Buckley PF, Harvey PD, Weiden PJ. Ginsberg DL, et al. Among authors: harvey pd. CNS Spectr. 2005 Feb;10(2):1-13; discussion 14-15. doi: 10.1017/s1092852900019337. CNS Spectr. 2005. PMID: 15803622

7

The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.

Friedman JI, Ocampo R, Elbaz Z, Parrella M, White L, Bowler S, Davis KL, Harvey PD. Friedman JI, et al. Among authors: harvey pd. J Clin Psychopharmacol. 2005 Jun;25(3):237-42. doi: 10.1097/01.jcp.0000161499.58266.51. J Clin Psychopharmacol. 2005. PMID: 15876902 Clinical Trial.

8

From clinical research to clinical practice: a 4-year review of ziprasidone.

Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, Kilts CD, Daniel DG. Nemeroff CB, et al. Among authors: harvey pd. CNS Spectr. 2005 Nov;10(11 Suppl 17):1-20. doi: 10.1017/s1092852900019842. CNS Spectr. 2005. PMID: 16381088

9

Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.

Harvey PD, Bowie CR, Loebel A. Harvey PD, et al. J Neuropsychiatry Clin Neurosci. 2006 Winter;18(1):54-63. doi: 10.1176/jnp.18.1.54. J Neuropsychiatry Clin Neurosci. 2006. PMID: 16525071 Clinical Trial.

10

The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

Harvey PD, Green MF, Bowie C, Loebel A. Harvey PD, et al. Psychopharmacology (Berl). 2006 Aug;187(3):356-63. doi: 10.1007/s00213-006-0432-1. Epub 2006 Jun 17. Psychopharmacology (Berl). 2006. PMID: 16783539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

835 results

Search Page

Filters